A novel in silico approach to identify potential therapeutic targets in human bacterial pathogens

38Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In recent years, genome-sequencing projects of pathogens and humans have revolutionized microbial drug target identification. Of the several known genomic strategies, subtractive genomics has been successfully utilized for identifying microbial drug targets. The present work demonstrates a novel genomics approach in which codon adaptation index (CAI), a measure used to predict the translational efficiency of a gene based on synonymous codon usage, is coupled with subtractive genomics approach for mining potential drug targets. The strategy adopted is demonstrated using respiratory pathogens, namely, Streptococcus pneumoniae and Haemophilus influenzae as examples. Our approach identified 8 potent target genes (Streptococcus pneumoniae-2, H. influenzae-6), which are functionally significant and also play key role in host-pathogen interactions. This approach facilitates swift identification of potential drug targets, thereby enabling the search for new inhibitors. These results underscore the utility of CAI for enhanced in silico drug target identification. © 2011 Springer Science+Business Media B.V.

Cite

CITATION STYLE

APA

Vetrivel, U., Subramanian, G., & Dorairaj, S. (2011). A novel in silico approach to identify potential therapeutic targets in human bacterial pathogens. HUGO Journal, 5(1–4), 25–34. https://doi.org/10.1007/s11568-011-9152-7

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free